Influence of the route of administration on the pharmacokinetics of amikacin. 1981

J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho

The pharmacokinetics of amikacin was studied in 17 hospitalized patients with normal renal function (creatinine clearance greater than 90 ml/min), after the administration of a single dose of 7.5 mg/kg body weight. In 10 patients the antibiotic was administered intravenously and in the other 7 it was injected intramuscularly. After i.v. administration, the antibiotic followed an open two-compartment kinetic model, and after i.m. administration it followed a single compartment kinetic model. The route of administration did not significantly modify the pharmacokinetic parameters of amikacin. On the basis of the pharmacokinetic parameters thus established, an intravenous infusion for therapeutic use should have an administration rate of 2.5 [mg/kg/h] and a duration of 6 h.

UI MeSH Term Description Entries
D007273 Injections, Intramuscular Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it. Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
December 1983, Journal of pharmacokinetics and biopharmaceutics,
J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
December 2013, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
September 1989, Zhongguo yao li xue bao = Acta pharmacologica Sinica,
J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
January 1993, Chirality,
J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
January 2015, Chirality,
J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
January 1991, Fundamental & clinical pharmacology,
J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
June 1987, The Japanese journal of antibiotics,
J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
October 1982, Pediatric research,
J M Lanao, and A Dominguez-Gil, and J M Tabernero, and L Corbacho
March 1992, Methods and findings in experimental and clinical pharmacology,
Copied contents to your clipboard!